JF
TVTX icon

Jump Financial’s Travere Therapeutics TVTX Stock Holding History

Jump Financial’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,632
Closed -$1.78M – 2409
2025
Q4 		$1.78M Sell
46,632
-268,398
-85% -$8.73M 0.02% 728
2025
Q3 		$7.53M Buy
+315,030
New +$5.92M 0.09% 287
2025
Q1 		– Sell
-76,842
Closed -$1.34M – 2029
2024
Q4 		$1.34M Sell
76,842
-199,688
-72% -$3.53M 0.03% 649
2024
Q3 		$3.87M Buy
276,530
+239,050
+638% +$2.49M 0.08% 292
2024
Q2 		$308K Sell
37,480
-33,631
-47% -$227K 0.01% 1369
2024
Q1 		$548K Buy
71,111
+51,687
+266% +$436K 0.01% 1127
2023
Q4 		$175K Sell
19,424
-169,501
-90% -$1.23M 0.01% 1596
2023
Q3 		$1.69M Buy
188,925
+132,067
+232% +$1.86M 0.06% 442
2023
Q2 		$873K Buy
+56,858
New +$1.03M 0.03% 752
2022
Q4 		– Sell
-10,757
Closed -$265K – 2031
2022
Q3 		$265K Sell
10,757
-49,943
-82% -$1.29M 0.01% 1211
2022
Q2 		$1.47M Buy
60,700
+20,100
+50% +$505K 0.06% 436
2022
Q1 		$1.05M Buy
40,600
+30,372
+297% +$806K 0.04% 508
2021
Q4 		$317K Buy
+10,228
New +$288K 0.02% 864
2021
Q3 		– Sell
-13,200
Closed -$193K – 1512
2021
Q2 		$193K Buy
+13,200
New +$260K 0.02% 884

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jump Financial's TVTX Position: Q1 2026 in Review

Jump Financial sold out of Travere Therapeutics (TVTX) in Q1 2026, closing a stake of 46,632 shares — an estimated $1.78M sold.

Jump Financial first reported a position in TVTX in Q2 2021 and held it in 14 quarters. The position peaked at $7.53M in Q3 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Jump Financial reported no remaining Travere Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 46,632 Travere Therapeutics shares in Q1 2026, an estimated $1.78M.
  • Jump Financial first reported a position in Travere Therapeutics in Q2 2021 and held it in 14 quarters.
  • Jump Financial's Travere Therapeutics position peaked at $7.53M in Q3 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.